Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
Leeds Vascular Institute, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
J Vasc Access. 2022 Sep;23(5):832-838. doi: 10.1177/11297298211006994. Epub 2021 Apr 12.
Patients who commence haemodialysis (HD) through arteriovenous fistulae and grafts (AVF/G) have improved survival compared to those who do so by venous lines.
This systematic review aims to assimilate the evidence for any strategy which increases the proportion of HD patients starting dialysis through AVF/G.
Medline, Embase, Cochrane Central and Scopus.
STUDY ELIGIBILITY, PARTICIPANTS AND INTERVENTIONS: English language studies comparing any educational, clinical or service organisation intervention for adult patients with end stage renal failure and reporting incident AVF/G use.
Two reviewers assessed studies for eligibility independently. Outcome data was extracted and reported as relative risk. Reporting was performed with reference to the PRISMA statement.
Of 1272 studies, 6 were eligible for inclusion. Studies varied in design and intervention. Formal meta-analysis was not appropriate. One randomised controlled trial and two cohort studies assessed the role of a renal access coordinator. Two cohort studies assessed the implementation of qualitive initiative programmes and one cohort study assessed a national, structured education programme. Results between studies were contradictory with some reporting improvements in incident AVF/G use and some no significant difference. Quality was generally low.
It is not possible to reach firm conclusions nor make strategic recommendations. A comprehensive package of care which educates and identifies patients approaching dialysis in a timely manner may improve incident AVF/G use. An unbiased, robust comparison of different strategies for timing AVF/G referral is required.
与通过静脉置管开始血液透析(HD)的患者相比,通过动静脉瘘和移植物(AVF/G)开始 HD 的患者的生存率更高。
本系统评价旨在综合评估任何增加通过 AVF/G 开始透析的 HD 患者比例的策略的证据。
Medline、Embase、Cochrane 中心和 Scopus。
研究入选标准、参与者和干预措施:比较任何针对终末期肾衰竭成年患者的教育、临床或服务组织干预,并报告事件性 AVF/G 使用的英语研究。
两名审查员独立评估研究的合格性。提取并报告了结果数据作为相对风险。报告遵循 PRISMA 声明。
在 1272 项研究中,有 6 项符合纳入标准。研究设计和干预措施各不相同。不适合进行正式的荟萃分析。一项随机对照试验和两项队列研究评估了肾脏通路协调员的作用。两项队列研究评估了定性倡议计划的实施,一项队列研究评估了国家结构化教育计划。研究结果相互矛盾,一些报告表明事件性 AVF/G 使用有所改善,而一些则没有显著差异。质量普遍较低。
无法得出明确的结论,也无法提出战略建议。综合护理方案,包括教育和及时识别即将接受透析的患者,可能会提高事件性 AVF/G 的使用。需要对不同的 AVF/G 转介时间策略进行无偏见、稳健的比较。